decorative image
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
decorative image
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

n/a Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.

Policy and Regulation on Registration and Reporting

This page provides background on how NIH’s clinical trials dissemination policy relates to the federal regulation (FDAAA Section 801 as implemented by 42 CFR Part 11).

Both the NIH policy and the federal regulation aim to increase the availability of information to the public about clinical trials – information that is not systematically available from other public sources. The regulation and NIH policy do not affect the design or conduct of clinical trials or define what type of data should be collected during a clinical trial. Rather, they aim to help ensure that information about clinical trials and their results are made publicly available, in a timely manner, via, a publicly accessible database operated by the NIH’s National Library of Medicine (NLM).

HHS logo FDAAA, Section 801, and the Final Rule (42 CFR Part 11)

Section 801 of the Food and Drug Administration Amendments Act (FDAAA 801) Link to Non-U.S. Government Site - Click for Disclaimer refers to a federal statute established in 2007 requiring the registration and reporting of information on "applicable clinical trials" on

In 2016, the Department of Health and Human Services (HHS) issued a regulation to further increase the availability of information about clinical trials, and clarify FDAAA 801. This regulation, 42 CFR Part 11  Link to Non-U.S. Government Site - Click for Disclaimer , is called the Final Rule for Clinical Trials Registration and Results Information Submission, or "Final Rule". The Final Rule describes requirements for registering and submitting summary results information for certain clinical trials to The changes made to FDAAA 801 by the Final Rule are available as a summary and table (PDF) Link to Non-U.S. Government Site - Click for Disclaimer .

NIH logo NIH's Clinical Trials Dissemination Policy

A complementary NIH policy applies to all clinical trials funded by NIH, regardless of whether they are subject to the Final Rule. The NIH Policy on Dissemination of NIH-Funded Clinical Trial Information, effective for competing applications and contract proposals submitted on or after January 18, 2017, states that all NIH-funded awardees and investigators conducting clinical trials will register and report the results of their trial in 

NIH is delaying enforcement of this policy until September 24, 2024 for basic experimental studies with humans (see NOT-OD-18-212, and NOT-OD-22-205). NIH will continue to expect registration and reporting for these types of studies.

Additional Resources

Further Reading